MAPT and early-onset autosomal dominant Alzheimer disease: Research from our group has previously demonstrated that these sites are less likely to be phosphorylated compared to other tau sites and are inversely associated with amyloid PET.10 Collectively, these tau phosphorylation sites have a lack of specificity for Alzheimer’s disease pathology.